Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125819061 | 12581906 | 1 | I | 20160413 | 20160722 | 20160722 | EXP | US-STRIDES ARCOLAB LIMITED-2016SP002635 | STRIDES | 0.00 | Y | 0.00000 | 20160722 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125819061 | 12581906 | 1 | PS | MYCOPHENOLATE MOFETIL. | MYCOPHENOLATE MOFETIL | 1 | UNK | 90055 | |||||||||||
| 125819061 | 12581906 | 2 | SS | MYCOPHENOLATE MOFETIL. | MYCOPHENOLATE MOFETIL | 1 | UNK | 90055 | |||||||||||
| 125819061 | 12581906 | 3 | SS | MYCOPHENOLATE MOFETIL. | MYCOPHENOLATE MOFETIL | 1 | UNK | 90055 | |||||||||||
| 125819061 | 12581906 | 4 | SS | MYCOPHENOLATE MOFETIL. | MYCOPHENOLATE MOFETIL | 1 | 250 MG, BID | 90055 | 250 | MG | |||||||||
| 125819061 | 12581906 | 5 | SS | MYCOPHENOLATE MOFETIL. | MYCOPHENOLATE MOFETIL | 1 | 500 MG, BID | 90055 | 500 | MG | |||||||||
| 125819061 | 12581906 | 6 | C | PREDNISOLONE. | PREDNISOLONE | 1 | UNK | 0 | |||||||||||
| 125819061 | 12581906 | 7 | C | PREDNISOLONE. | PREDNISOLONE | 1 | UNK | 0 | |||||||||||
| 125819061 | 12581906 | 8 | C | TACROLIMUS. | TACROLIMUS | 1 | UNK | 0 | |||||||||||
| 125819061 | 12581906 | 9 | C | TACROLIMUS. | TACROLIMUS | 1 | UNK | 0 | |||||||||||
| 125819061 | 12581906 | 10 | C | SIROLIMUS. | SIROLIMUS | 1 | UNK | 0 | |||||||||||
| 125819061 | 12581906 | 11 | C | CIPROFLOXACIN. | CIPROFLOXACIN | 1 | UNK | 0 | |||||||||||
| 125819061 | 12581906 | 12 | C | CORTICOSTEROIDS | CORTICOSTEROID NOS | 1 | Intravenous (not otherwise specified) | UNK | 0 | ||||||||||
| 125819061 | 12581906 | 13 | C | IMMUNOGLOBULINS | HUMAN IMMUNOGLOBULIN G | 1 | Intravenous (not otherwise specified) | 100 MG/KG, ONCE A WEEK | 0 | 100 | MG/KG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125819061 | 12581906 | 1 | Immunosuppression |
| 125819061 | 12581906 | 6 | Immunosuppression |
| 125819061 | 12581906 | 8 | Immunosuppression |
| 125819061 | 12581906 | 10 | Polyomavirus-associated nephropathy |
| 125819061 | 12581906 | 11 | Polyomavirus-associated nephropathy |
| 125819061 | 12581906 | 12 | Heart transplant rejection |
| 125819061 | 12581906 | 13 | Polyomavirus-associated nephropathy |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125819061 | 12581906 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125819061 | 12581906 | Leukopenia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |